AN
58
4
INTC
33
-2
IR
66
3
AA
48
-12
MCHP
41
4
PPL
54
-5
BF.B
33
2
NTAP
67
-3
CL
58
2
DD
63
3
PFG
45
3
SWK
64
5
TGT
22
2
UNP
52
7
ACN
52
3
DG
6
2
XYL
49
4
AVY
53
3
UA
50
-9
NVDA
56
-4
AN
58
4
INTC
33
-2
IR
66
3
AA
48
-12
MCHP
41
4
PPL
54
-5
BF.B
33
2
NTAP
67
-3
CL
58
2
DD
63
3
PFG
45
3
SWK
64
5
TGT
22
2
UNP
52
7
ACN
52
3
DG
6
2
XYL
49
4
AVY
53
3
UA
50
-9
NVDA
56
-4
Financhill
Back

Alnylam Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
244.97
Seasonality Move:
11.66%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $244.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.65 Sell
Relative Strength Index (14 RSI): 37.82 Sell
Chaikin Money Flow: -229766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (250.02 - 288.16) Sell
Bollinger Bands (100): (248.72 - 281.72) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 245.62 Sell
20-day SMA: 263.27 Sell
50-day SMA: 272.49 Sell
200-day SMA: 211.63 Buy
8-day EMA: 248.36 Sell
20-day EMA: 259.36 Sell
50-day EMA: 265.3 Sell
200-day EMA: 231.03 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):